Meta-Analysis
Copyright ©The Author(s) 2024.
World J Gastroenterol. Mar 14, 2024; 30(10): 1450-1460
Published online Mar 14, 2024. doi: 10.3748/wjg.v30.i10.1450
Figure 1
Figure 1 PRISMA study selection flow diagram.
Figure 2
Figure 2 Standardized mean difference of liver stiffness. A: Standardized mean difference (SMD) of liver stiffness (LS) at baseline in patients who did or did not develop hepatocellular carcinoma (HCC) during follow-up; B: SMD of LS at 12 wk after sustained virological response (SVR) in patients who did or did not develop HCC during follow-up; C: SMD of LS at 24 wk after SVR in patients who did or did not develop HCC during follow-up. 95%CI: 95% Confidence interval.